<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:entx="http://www.enterabio.com/20260630"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="entx-20260630.xsd" xlink:type="simple"/>
    <context id="C_20260101to20260630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260101_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:FiveNonExecutiveMembersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-01</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260201to20260228_srtTitleOfIndividualAxis_entxFormerNonExecutiveBoardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:FormerNonExecutiveBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="C_20260630_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260101to20260630_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260101_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-01</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_srtTitleOfIndividualAxis_entxEmployeesMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_srtTitleOfIndividualAxis_entxServiceProvidersMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:ServiceProvidersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_srtTitleOfIndividualAxis_entxDirectorOneMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:DirectorOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_srtTitleOfIndividualAxis_entxDirectorTwoMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">entx:DirectorTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260507to20260507_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <context id="C_20241231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20251231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20250630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20260630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260401to20260401_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-04-01</endDate>
        </period>
    </context>
    <context id="C_20260402to20260402_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="C_20260402to20260402_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="C_20260402to20260402_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-02</startDate>
            <endDate>2026-04-02</endDate>
        </period>
    </context>
    <context id="C_20260402_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="C_20260402_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-02</instant>
        </period>
    </context>
    <context id="C_20260401_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputSharePriceMember_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-01</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputSharePriceMember_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputSharePriceMember_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-01</instant>
        </period>
    </context>
    <context id="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:OpkoBiologicsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-11</startDate>
            <endDate>2025-03-16</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:OpkoBiologicsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:OpkoBiologicsLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-08-03</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20260331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_20250331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_20260101to20260630_usgaapStatementBusinessSegmentsAxis_entxSingleReportableSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">entx:SingleReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="C_20260701to20260728_usgaapClassOfWarrantOrRightAxis_entxPreFundedWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">entx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-28</endDate>
        </period>
    </context>
    <context id="C_20260701to20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-26</endDate>
        </period>
    </context>
    <context id="C_20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-26</instant>
        </period>
    </context>
    <context id="C_20260726_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-26</instant>
        </period>
    </context>
    <context id="C_20260701to20260726_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_entxTwoZeroTwoThreePrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">entx:TwoZeroTwoThreePrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-26</endDate>
        </period>
    </context>
    <context id="C_20260701to20260726_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_entxTwoZeroTwoThreePrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:TwoZeroTwoSixPrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">entx:TwoZeroTwoThreePrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-26</endDate>
        </period>
    </context>
    <context id="C_20260701to20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_entxTwoZeroTwoThreePrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">entx:TwoZeroTwoThreePrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-26</endDate>
        </period>
    </context>
    <context id="C_20260701to20260728_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-28</endDate>
        </period>
    </context>
    <context id="C_20260728_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">entx:OrdinaryShareWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">entx:BvfPartnersLpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-28</instant>
        </period>
    </context>
    <context id="C_20260701to20260714_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-07-14</endDate>
        </period>
    </context>
    <context id="C_20260801to20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_entxFiveNonExecutiveBoardMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">entx:FiveNonExecutiveBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-01</startDate>
            <endDate>2026-08-05</endDate>
        </period>
    </context>
    <context id="C_20220901to20220930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20260801to20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtDirectorMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-01</startDate>
            <endDate>2026-08-05</endDate>
        </period>
    </context>
    <context id="C_20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtDirectorMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-05</instant>
        </period>
    </context>
    <unit id="NIS_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>entx:Segment</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_20260101to20260630"
      id="F20230807213857684_19">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="C_20260101to20260630"
      id="Fdei_EntityCentralIndexKey20220219150840900">0001638097</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20260101to20260630"
      id="Fdei_AmendmentFlag20220219150858854">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20260101to20260630"
      id="Fdei_DocumentFiscalPeriodFocus20220219151109286">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20260101to20260630"
      id="Fdei_CurrentFiscalYearEndDate20220506104715921">--12-31</dei:CurrentFiscalYearEndDate>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260630"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250630"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20251107164113212"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250401to20250630"
      id="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20260803123957508_xbrl_20251107164113212"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260401to20260630"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_20260101to20260630_usgaapStatementBusinessSegmentsAxis_entxSingleReportableSegmentMember"
      decimals="0"
      id="Fxbrl_20260804213019803"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_20260101to20260630_usgaapStatementBusinessSegmentsAxis_entxSingleReportableSegmentMember"
      decimals="0"
      id="Fxbrl_20260804213855092"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <dei:DocumentType
      contextRef="C_20260101to20260630"
      id="Fxbrl_20231101130936027">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="C_20260101to20260630" id="F20230807213857678_1">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20260101to20260630"
      id="F20230807213857685_25">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20260101to20260630"
      id="F20230807213857685_26">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_20260101to20260630" id="F20230807213857679_2">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_20260101to20260630" id="F20230807213857679_3">001-38556</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501204020610">ENTERA BIO LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20260101to20260630"
      id="F20230807213857684_18">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="C_20260101to20260630" id="F20230807213857679_4">Kiryat Hadassah</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_20260101to20260630" id="F20230807213857679_5">Minrav Building &#x2013; Fifth Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_20260101to20260630" id="F20230807213857680_6">Jerusalem</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="C_20260101to20260630"
      id="F20230807213857683_17">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260101to20260630"
      id="Fxbrl_20241103190453128_20230807213857680_7">9112002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_20260101to20260630" id="F20230807213857681_8">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_20260101to20260630" id="F20230807213857682_9">2-532-7151</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_20260101to20260630"
      id="Fxbrl_20240507011622543">Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20260101to20260630"
      id="Fxbrl_20241103190453129_20230807213857682_11">ENTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20260101to20260630"
      id="Fxbrl_20240802153127672">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20260101to20260630"
      id="F20230807213857685_24">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501204045660">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20260101to20260630"
      id="Fxbrl_20231101131214875">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_20260101to20260630"
      id="Fxbrl_20241103190453133_xbrl_20231101130810468">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20260101to20260630"
      id="Fxbrl_20241103190453134_20230807213857683_16">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="C_20260101to20260630"
      id="F20230807213857685_22">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20260803"
      decimals="INF"
      id="Fxbrl_20260506092608052"
      unitRef="shares">173141831</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429362_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_33"
      unitRef="USD">11309000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429362_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_37"
      unitRef="USD">7108000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250506012844619"
      unitRef="USD">7122000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250506012853875"
      unitRef="USD">7775000</us-gaap:RestrictedCash>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429378_xbrl_20240506175250775_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_33"
      unitRef="USD">465000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429378_xbrl_20240506175250775_xbrl_20220808213205256_xbrl_20220802012333935_xbrl_20220505162133424_xbrl_20220219060830028_37"
      unitRef="USD">415000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429383_xbrl_20220808213205268_xbrl_20220802012333953_xbrl_20220505162133436_xbrl_20220219060830028_63"
      unitRef="USD">18896000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429383_xbrl_20220808213205268_xbrl_20220802012333953_xbrl_20220505162133436_xbrl_20220219060830028_67"
      unitRef="USD">15298000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429392_xbrl_20220808213205274_xbrl_20220802012333958_xbrl_20220505162133439_xbrl_20220219060830028_83"
      unitRef="USD">121000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429392_xbrl_20220808213205274_xbrl_20220802012333958_xbrl_20220505162133439_xbrl_20220219060830028_87"
      unitRef="USD">134000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429406_xbrl_20220808213205277_xbrl_20220802012333963_xbrl_20220505162133441_xbrl_20220219060830028_93"
      unitRef="USD">362000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429406_xbrl_20220808213205277_xbrl_20220802012333963_xbrl_20220505162133441_xbrl_20220219060830028_97"
      unitRef="USD">465000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250506012955555"
      unitRef="USD">95000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250506013004546"
      unitRef="USD">90000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429435_xbrl_20220808213205284_xbrl_20220802012333974_xbrl_20220505162133446_xbrl_20220219060830028_103"
      unitRef="USD">6000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429435_xbrl_20220808213205284_xbrl_20220802012333974_xbrl_20220505162133446_xbrl_20220219060830028_107"
      unitRef="USD">6000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429445_xbrl_20220808213205287_xbrl_20220802012333980_xbrl_20220505162133448_xbrl_20220219060830028_113"
      unitRef="USD">584000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429445_xbrl_20220808213205287_xbrl_20220802012333980_xbrl_20220505162133448_xbrl_20220219060830028_117"
      unitRef="USD">695000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429462_xbrl_20220808213205289_xbrl_20220802012333985_xbrl_20220505162133450_xbrl_20220219060830028_123"
      unitRef="USD">19480000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429462_xbrl_20220808213205289_xbrl_20220802012333985_xbrl_20220505162133450_xbrl_20220219060830028_127"
      unitRef="USD">15993000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429468_xbrl_20220808213205292_xbrl_20220802012333989_xbrl_20220505162133452_xbrl_20220219060830028_153"
      unitRef="USD">575000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429468_xbrl_20220808213205292_xbrl_20220802012333989_xbrl_20220505162133452_xbrl_20220219060830028_157"
      unitRef="USD">448000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429476_xbrl_20220808213205294_xbrl_20220802012333994_xbrl_20220505162133454_xbrl_20220219060830028_163"
      unitRef="USD">1330000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429476_xbrl_20220808213205294_xbrl_20220802012333994_xbrl_20220505162133454_xbrl_20220219060830028_167"
      unitRef="USD">1525000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429483_xbrl_20220808213205297_xbrl_20220802012333998_xbrl_20220505162133457_xbrl_20220219060830028_173"
      unitRef="USD">199000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429483_xbrl_20220808213205297_xbrl_20220802012333998_xbrl_20220505162133457_xbrl_20220219060830028_177"
      unitRef="USD">230000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429490_xbrl_20220808213205301_xbrl_20220802012334009_xbrl_20220505162133460_xbrl_20220219060830028_193"
      unitRef="USD">2104000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429490_xbrl_20220808213205301_xbrl_20220802012334009_xbrl_20220505162133460_xbrl_20220219060830028_197"
      unitRef="USD">2203000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429496_xbrl_20230731132348860_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD">226000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429496_xbrl_20230731132348860_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD">260000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250506013228511"
      unitRef="USD">284000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250506013239493"
      unitRef="USD">393000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD">37000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD">36000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20260803100212414_xbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD">9563000</entx:PreFundedWarrantsLiability>
    <entx:PreFundedWarrantsLiability
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20260803100212414_xbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD">0</entx:PreFundedWarrantsLiability>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429511_xbrl_20220808213205308_xbrl_20220802012334025_xbrl_20220505162133467_xbrl_20220219060830028_233"
      unitRef="USD">10110000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429511_xbrl_20240506175318992"
      unitRef="USD">689000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429518_xbrl_20220808213205310_xbrl_20220802012334031_xbrl_20220505162133469_xbrl_20220219060830028_243"
      unitRef="USD">12214000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429518_xbrl_20220808213205310_xbrl_20220802012334031_xbrl_20220505162133469_xbrl_20220219060830028_247"
      unitRef="USD">2892000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20260630"
      id="Fxbrl_20260803152540223_xbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20251231"
      id="Fxbrl_20260803152540223_xbrl_20241103165429504_xbrl_20220808213205306_xbrl_20220802012334021_xbrl_20220505162133465_xbrl_20220219060830028_227"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20220809034950441"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20260630"
      decimals="INF"
      id="Fxbrl_20220808214817829"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20220809035007189"
      unitRef="shares">140010000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20260630"
      decimals="INF"
      id="Fxbrl_20220808214936276"
      unitRef="shares">140010000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20260630"
      decimals="INF"
      id="Fxbrl_20250506013325802"
      unitRef="shares">49290233</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20260630"
      decimals="INF"
      id="Fxbrl_20220808215259598"
      unitRef="shares">49290233</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_s_20251107004543855"
      unitRef="shares">46178630</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20251231"
      decimals="INF"
      id="Fxbrl_20251107004543855"
      unitRef="shares">46178630</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20220808213249447"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20220808214617486"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429530_xbrl_20220808213205314_xbrl_20220802012334039_xbrl_20220505162133472_xbrl_20220219060830028_283"
      unitRef="USD">143407000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429530_xbrl_20220808213205314_xbrl_20220802012334039_xbrl_20220505162133472_xbrl_20220219060830028_287"
      unitRef="USD">138425000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429539_xbrl_20220808213205316_xbrl_20220802012334043_xbrl_20220505162133474_xbrl_20220219060830028_293"
      unitRef="USD">41000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429539_xbrl_20220808213205316_xbrl_20220802012334043_xbrl_20220505162133474_xbrl_20220219060830028_297"
      unitRef="USD">41000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429546_xbrl_20230731132604195"
      unitRef="USD">-136183000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429546_xbrl_20220808213205318_xbrl_20220802012334047_xbrl_20220505162133476_xbrl_20220219060830028_307"
      unitRef="USD">-125366000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429554_xbrl_20220808213205320_xbrl_20220802012334050_xbrl_20220505162133478_xbrl_20220219060830028_313"
      unitRef="USD">7266000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429554_xbrl_20220808213205320_xbrl_20220802012334050_xbrl_20220505162133478_xbrl_20220219060830028_317"
      unitRef="USD">13101000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103165429563_xbrl_20220808213205323_xbrl_20220802012334055_xbrl_20220505162133480_xbrl_20220219060830028_323"
      unitRef="USD">19480000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103165429563_xbrl_20220808213205323_xbrl_20220802012334055_xbrl_20220505162133480_xbrl_20220219060830028_327"
      unitRef="USD">15993000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034286_xbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034286_xbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802123117231"
      unitRef="USD">42000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802063145927_xbrl_20241103170649902_xbrl_20240802124332710_xbrl_20240802123117231"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034289_xbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034289_xbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802123117231"
      unitRef="USD">42000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802063145929_xbrl_20241103170649916_xbrl_20240802124334630_xbrl_20240802123117231"
      unitRef="USD">0</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034292_xbrl_20250802063145931_xbrl_20241103170649932_xbrl_20240802124336495_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034292_xbrl_20250802063145931_xbrl_20250802063020103"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802063145931_xbrl_20241103170649932_xbrl_20240802124336495_xbrl_20240802122721947"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802063145931_xbrl_20250802063020103"
      unitRef="USD">0</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034294_xbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802122721947"
      unitRef="USD">5452000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034294_xbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802123117231"
      unitRef="USD">2643000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802122721947"
      unitRef="USD">3201000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802063145932_xbrl_20241103170649946_xbrl_20240802123117231"
      unitRef="USD">1520000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034297_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">2650000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034297_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">2588000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">1362000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">1148000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034300_xbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">8102000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034300_xbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">5231000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">4563000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20251107152606249_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">2668000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034303_xbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-8102000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034303_xbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-5231000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-4563000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20251107152608066_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-2668000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034306_xbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802122812921"
      unitRef="USD">-2715000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034306_xbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802123155891"
      unitRef="USD">8000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802122812921"
      unitRef="USD">-2749000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802063145936_xbrl_20241103170650070_xbrl_20240802123155891"
      unitRef="USD">12000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803101034309_xbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-10817000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803101034309_xbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-5223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802122735326"
      unitRef="USD">-7312000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20251107152610008_xbrl_20250802063145933_xbrl_20241103170649967_xbrl_20240802123125629"
      unitRef="USD">-2656000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260101to20260630"
      decimals="2"
      id="Fxbrl_20260803182533523"
      unitRef="USD_per_Share">0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260101to20260630"
      decimals="2"
      id="Fxbrl_20260803182526419"
      unitRef="USD_per_Share">0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250101to20250630"
      decimals="2"
      id="Fxbrl_s_20260803182619604"
      unitRef="USD_per_Share">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250101to20250630"
      decimals="2"
      id="Fxbrl_20260803182619604"
      unitRef="USD_per_Share">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20260401to20260630"
      decimals="2"
      id="Fxbrl_s_20260803182635493"
      unitRef="USD_per_Share">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20260401to20260630"
      decimals="2"
      id="Fxbrl_20260803182635493"
      unitRef="USD_per_Share">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20250401to20250630"
      decimals="2"
      id="Fxbrl_s_20260803182650864"
      unitRef="USD_per_Share">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20250401to20250630"
      decimals="2"
      id="Fxbrl_20260803182650864"
      unitRef="USD_per_Share">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260101to20260630"
      decimals="INF"
      id="Fxbrl_20260804202656542"
      unitRef="shares">49098428</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20260101to20260630"
      decimals="INF"
      id="Fxbrl_20260803182914853"
      unitRef="shares">49098428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250101to20250630"
      decimals="INF"
      id="Fxbrl_s_20260803182940275"
      unitRef="shares">45146415</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20250101to20250630"
      decimals="INF"
      id="Fxbrl_20260803182940276"
      unitRef="shares">45146415</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20260401to20260630"
      decimals="INF"
      id="Fxbrl_s_20260803183020058"
      unitRef="shares">50451232</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20260401to20260630"
      decimals="INF"
      id="Fxbrl_20260803183020058"
      unitRef="shares">50451232</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20250401to20250630"
      decimals="INF"
      id="Fxbrl_s_20260803183049033"
      unitRef="shares">46836700</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20250401to20250630"
      decimals="INF"
      id="Fxbrl_20260803183049034"
      unitRef="shares">46836700</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_66"
      unitRef="shares">46178630</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808214535386"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802162836869"
      unitRef="USD">138425000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_63"
      unitRef="USD">-125366000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_62"
      unitRef="USD">13101000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-10817000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-10817000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="USD">394748000</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">260000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">260000</entx:ExerciseOfOptionsValue>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">2425000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">3137000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">3137000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">142983</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <entx:SettlementInShareOfBoardMembersCompensationShares
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">148872</entx:SettlementInShareOfBoardMembersCompensationShares>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">289000</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:SettlementInShareOfBoardMembersCompensation>
    <entx:SettlementInShareOfBoardMembersCompensation
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20250506042924990_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">289000</entx:SettlementInShareOfBoardMembersCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250506041923331"
      unitRef="USD">1296000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250506041935570"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20250506041944631"
      unitRef="USD">1296000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">49290233</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">143407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-136183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">7266000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_66"
      unitRef="shares">46622239</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808214535386"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_65"
      unitRef="USD">139516000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_63"
      unitRef="USD">-128871000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260331"
      decimals="-3"
      id="Fxbrl_20250802111356935_xbrl_20241103185419677_xbrl_20231023161813955_xbrl_20230731141710655_xbrl_20220808213010611_20220801223211821_62"
      unitRef="USD">10687000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-7312000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802111409814_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-7312000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="USD">178082000</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">130000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">130000</entx:ExerciseOfOptionsValue>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">2425000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCostsShares>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">3137000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">3137000</entx:IssuanceOfOrdinarySharesAndWarrantsNetOfIssuanceCosts>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">64912</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041923331"
      unitRef="USD">624000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041935570"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802111459532_xbrl_20250506041944631"
      unitRef="USD">624000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">49290233</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">143407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-136183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">7266000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">38837220</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">121965000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-113927000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20260803123704691_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">8080000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-5223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803123732084_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-5223000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfWarrantsShares
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">149700</entx:ExerciseOfWarrantsShares>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">150000</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfWarrantsValue
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">150000</entx:ExerciseOfWarrantsValue>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="USD">23952000</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">24000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">24000</entx:ExerciseOfOptionsValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">3685226</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">7115000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">7115000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">2700000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">5997000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">5997000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">56069</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041923331"
      unitRef="USD">1113000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041935570"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803130134839_xbrl_20250802111459532_xbrl_20250506041944631"
      unitRef="USD">1113000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">45452167</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">136364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-119150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20260803123709097_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">17256000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">45420677</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">135831000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-116494000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250331"
      decimals="-3"
      id="Fxbrl_20260803123842630_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">19379000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20240802152950914"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211798_55"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_54"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_53"
      unitRef="USD">-2656000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20260803123736103_xbrl_20241103185424308_xbrl_20231023161952010_xbrl_20220808213010516_20220801223211791_52"
      unitRef="USD">-2656000</us-gaap:NetIncomeLoss>
    <entx:ExerciseOfOptionsToOrdinaryShares
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="USD">23952000</entx:ExerciseOfOptionsToOrdinaryShares>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
      unitRef="USD">24000</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</entx:ExerciseOfOptionsValue>
    <entx:ExerciseOfOptionsValue
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
      unitRef="USD">24000</entx:ExerciseOfOptionsValue>
    <entx:VestedRestrictedShareUnitsShares
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_50"
      unitRef="shares">7538</entx:VestedRestrictedShareUnitsShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_48"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211789_47"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041918452"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041923331"
      unitRef="USD">509000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041929267"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041935570"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20260803124015260_xbrl_20250802111459532_xbrl_20250506041944631"
      unitRef="USD">509000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_66"
      unitRef="shares">45452167</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20230430155759086"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_65"
      unitRef="USD">136364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapAccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211822_64"
      unitRef="USD">41000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_63"
      unitRef="USD">-119150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20260803123712582_xbrl_20250802111841564_xbrl_20250802111505709_xbrl_20241103185459254_xbrl_20231023162025941_xbrl_20220808213412916_20220801223211821_62"
      unitRef="USD">17256000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541059_xbrl_20220219041121835_33"
      unitRef="USD">-10817000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541059_xbrl_20220219041121835_37"
      unitRef="USD">-5223000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541067_xbrl_20220219041121835_63"
      unitRef="USD">16000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541067_xbrl_20220219041121835_67"
      unitRef="USD">15000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">1296000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">1113000</us-gaap:ShareBasedCompensation>
    <entx:FinanceIncomeExpensesNet
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803112148836_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">-18000</entx:FinanceIncomeExpensesNet>
    <entx:FinanceIncomeExpensesNet
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803112148836_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">-18000</entx:FinanceIncomeExpensesNet>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260804203455042"
      unitRef="USD">-2755000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260804203528849"
      unitRef="USD">0</us-gaap:OtherNoncashIncomeExpense>
    <entx:IssuanceCost
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803114946389_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">-116000</entx:IssuanceCost>
    <entx:IssuanceCost
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803114946389_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">0</entx:IssuanceCost>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541093_xbrl_20220219041121835_133"
      unitRef="USD">48000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541093_xbrl_20220219041121835_137"
      unitRef="USD">252000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803114951021_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803114951021_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">-126000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175555825_xbrl_20220802102026794"
      unitRef="USD">127000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175555825_xbrl_20230731140959224"
      unitRef="USD">251000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175600530_xbrl_20220219041121835_153"
      unitRef="USD">-17000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175600530_xbrl_20220219041121835_157"
      unitRef="USD">917000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541103_xbrl_20220219041121835_173"
      unitRef="USD">-6554000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541103_xbrl_20220305111416980"
      unitRef="USD">-3035000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541109_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">3000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541109_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">37000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541116_xbrl_20221030215741538"
      unitRef="USD">-3000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541116_xbrl_20221030215753542"
      unitRef="USD">-37000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803114959840_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">10000000</entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants>
    <entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803114959840_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">0</entx:ProceedsFromIssuanceOfOrdinarySharesWarrantsAndPreFundedWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541124_xbrl_20240802134235311_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541124_xbrl_20240802134235311_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">6183000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20250506041406242"
      unitRef="USD">171000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20250506041411832"
      unitRef="USD">261000</us-gaap:PaymentsOfStockIssuanceCosts>
    <entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20250506041435220"
      unitRef="USD">0</entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement>
    <entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20250506041440476"
      unitRef="USD">7190000</entx:ProceedsFromIssuanceOfSharesUnderCollaborationAgreement>
    <entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260803115004003_xbrl_20241103175541075_xbrl_20220219041121835_83"
      unitRef="USD">260000</entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares>
    <entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260803115004003_xbrl_20241103175541075_xbrl_20220219041121835_87"
      unitRef="USD">174000</entx:ExerciseOfWarrantsAndOptionsToOrdinaryShares>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541167_xbrl_20230731140302926_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">10089000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541167_xbrl_20230731140302926_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">13286000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541181_xbrl_20220219041121835_313"
      unitRef="USD">3532000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541181_xbrl_20220219041121835_317"
      unitRef="USD">10214000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260804204136954"
      unitRef="USD">21000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260804204205115"
      unitRef="USD">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103175541190_xbrl_20240506221453069_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_203"
      unitRef="USD">14973000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20241231"
      decimals="-3"
      id="Fxbrl_20241103175541190_xbrl_20240506221453069_xbrl_20230731140301139_xbrl_20230731140230697_xbrl_20221030215719839_xbrl_20220219041121835_207"
      unitRef="USD">8740000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103175541196_xbrl_20230426031130941"
      unitRef="USD">18526000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20241103175541196_xbrl_20230426031137438"
      unitRef="USD">18954000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103175541202_xbrl_20220505171612811"
      unitRef="USD">11309000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20241103175541202_xbrl_20220505171631694"
      unitRef="USD">10858000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250802063337635"
      unitRef="USD">7217000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20241103175541209_xbrl_20230426031246543"
      unitRef="USD">8096000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103175541216_xbrl_20240506221327972_xbrl_20230426031237262"
      unitRef="USD">18526000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20250630"
      decimals="-3"
      id="Fxbrl_20241103175541216_xbrl_20240506221327972_xbrl_20230426031246543"
      unitRef="USD">18954000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <entx:InterestReceived
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20241103175541223_xbrl_20240506215335901_xbrl_20230731140755339_xbrl_20230426031237262"
      unitRef="USD">100000</entx:InterestReceived>
    <entx:InterestReceived
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20241103175541223_xbrl_20240506215335901_xbrl_20230731140755339_xbrl_20230426031246543"
      unitRef="USD">57000</entx:InterestReceived>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20241103181931773">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 1 - DESCRIPTION OF BUSINESS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="vertical-align:top;width:40pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Entera Bio Ltd. (collectively with its subsidiary, the "Company") was incorporated on September 30, 2009 and commenced operation on June 1, 2010. On January 8, 2018, the Company incorporated its wholly owned subsidiary, Entera Bio Inc., in Delaware, United States.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is focused on developing first-in-class oral&#160; peptides. The Company focuses on underserved, chronic medical conditions for which oral administration of a protein therapy has the potential to significantly shift a treatment paradigm.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s most advanced product candidate, EB613, oral PTH(1-34), is being developed as the first oral, osteoanabolic (bone building) tablet treatment for post-menopausal women with osteoporosis. In February 2026, the Company submitted to the FDA a clinical amendment which included the EB613 Phase 3 protocol, statistical analysis plan and open-label extension synopsis. In June 2026, the Company received feedback from the FDA on the submitted Phase 3 protocol for EB613 and is planning to initiate the Phase 3 registrational study in late 2026. On July 28, 2026, the Company completed a private placement. The net proceeds from the private placement are expected to be used primarily to support activities related to the planned Phase 3 registrational study of EB613. See Note 8b for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s second product candidate, EB612, is being developed as the first oral PTH(1-34) tablet peptide replacement tablet for patients with hypoparathyroidism. In February 2026, the Company amended and restated the 2025 Collaboration Agreement (as defined in Note 6) with OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (&#x201c;OPKO&#x201d;), to advance the first oral long-acting PTH analog (&#x201c;LA-PTH&#x201d;) as a once-daily tablet for patients with hypoparathyroidism.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;In addition, EB618 is being developed pursuant to the Company&#x2019;s collaboration with OPKO, pursuant to which the companies are advancing a proprietary novel dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for patients with obesity, metabolic and fibrotic disorders.&lt;br/&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition to its internal product development programs, the Company intends to license its proprietary N-Tab&lt;sup style="vertical-align:text-top;line-height:1;font-size:smaller"&gt;&#xae;&lt;/sup&gt; platform to biopharmaceutical companies for use with their proprietary compounds.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;br/&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The Company&#x2019;s second product candidate, EB612, is being developed as the first oral PTH(1-34) tablet peptide replacement tablet for patients with hypoparathyroidism. In February 2026, the Company amended and restated the 2025 Collaboration Agreement (as defined in Note 6) with OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (&#x201c;OPKO&#x201d;), to advance the first oral long-acting PTH analog (&#x201c;LA-PTH&#x201d;) as a once-daily tablet for patients with hypoparathyroidism.&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:40pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's ordinary shares, NIS 0.0000769 par value per share (&#x201c;ordinary shares&#x201d;), are listed on the Nasdaq Capital Market under the symbol &#x201c;ENTX&#x201d;.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:40pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has incurred recurring operating losses and negative cash flows from operations since inception and expects to continue to incur operating losses as it advances the development of its product candidates. As of June 30, 2026, the Company has incurred an accumulated deficit in the amount of $136.2 million.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div&gt;&#160;&lt;/div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;As disclosed in Note 8b, in July 2026, the Company completed a private placement financing of an aggregate of 134,803,910 Ordinary Shares and pre-funded warrants to purchase Ordinary Shares resulting in gross proceeds of approximately $275.0 million, before deducting placement agent fees and other related offering expenses.&#160;The Company expects to use the net proceeds primarily to support activities related to the initiation of its Phase 3 registrational study of EB613, as well as for general working capital and corporate purposes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Following the closing of the private placement and receipt of the related net proceeds, management concluded that substantial doubt about the Company&#x2019;s ability to continue as a going concern no longer exists. Based on the Company's current operating plan, management believes that the Company's existing cash and cash equivalents, which includes the net proceeds from the private placement, will be sufficient to fund its planned operations for at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;line-height:1.25"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:top;width:43pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Since October 2023, Israel has been involved in an armed conflict with Hamas, which has expanded to include hostilities involving Hezbollah, Iran and other armed groups in the region. During the first half of 2026, military activity escalated, including direct military exchanges involving Israel, Iran and the United States, as well as renewed hostilities along Israel's northern border. Although ceasefire arrangements have been announced from time to time, the regional security situation remains uncertain, and there can be no assurance that hostilities will not continue or further escalate.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's research personnel and members of management are located in Israel, while its clinical, regulatory and supply chain activities are primarily conducted outside Israel. As of June 30, 2026, the Company's operations have remained largely unaffected by these events. For the six months ended June 30, 2026 and 2025, and for the year ended December 31, 2025, the impact of these events on the Company's results of operations and financial condition was not material.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20260630"
      decimals="7"
      id="Fxbrl_20230731131108454"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20260630"
      decimals="-5"
      id="Fxbrl_20260804204850772"
      unitRef="USD">-136200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20260701to20260728_usgaapClassOfWarrantOrRightAxis_entxPreFundedWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260804204922397"
      unitRef="shares">134803910</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260701to20260728_usgaapClassOfWarrantOrRightAxis_entxPreFundedWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-5"
      id="Fxbrl_20260804204940773"
      unitRef="USD">275000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20250802062623723">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basis of presentation of the financial statements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s consolidated financial position as of June 30, 2026, the consolidated results of operations and statements of changes in shareholders' equity for the three and six months ended June 30, 2026 and 2025, and cash flows for the six months ended June 30, 2026, and 2025.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated results of operations for the three and six months ended June 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company as of and for the year ended December 31, 2025, as filed with the Company&#x2019;s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 27, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="margin-top:0px;margin-bottom:0px"&gt;&lt;/div&gt;

        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss per share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="text-indent:-36pt;margin-left:72pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;asic loss per share is computed on the basis of net loss for the period divided by the weighted average number of outstanding ordinary shares, pre-funded warrants and vested restricted share units (&#x201c;RSUs&#x201d;) during the period. Each outstanding pre-funded warrant has no expiration and is exercisable at a price of NIS &lt;/span&gt;0.0000769&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt; per ordinary share.&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per share is based upon the weighted average number of ordinary shares and ordinary share equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, warrants and restricted share units (&#x201c;RSUs&#x201d;), which are included under the treasury stock method when dilutive. The calculation of diluted loss per share does not include options, warrants and RSUs exercisable into 31,712,061 ordinary shares and into 16,562,467 ordinary shares for the six months ended June 30, 2026 and 2025, respectively, and 34,357,716 ordinary shares and 17,068,031 ordinary shares for the three months ended June 30, 2026 and 2025, respectively, because the effect would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;

      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:42.55pt;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:7.6%;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="text-indent:-58.35pt;margin-left:108pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:42.55pt;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:7.6%;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Observable prices that are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="text-indent:-58.35pt;margin-left:108pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:42.55pt;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:7.6%;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
      &lt;div style="margin-top:0px;margin-bottom:0px"&gt;&lt;/div&gt;

        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Newly issued and recently adopted accounting pronouncements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recently issued accounting pronouncements not yet adopted&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2024, the FASB issued ASU&#160;2024-03 &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#x201d;, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its&#160;consolidated financial statements disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2025, the FASB issued ASU 2025-10 &#x201c;Government Grants (Topic 832)&#x201d; to establish authoritative guidance on the accounting for government grants received by business entities. This update is effective beginning with the Company&#x2019;s 2029 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501154955780">
        &lt;div style="line-height:1.25"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basis of presentation of the financial statements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s consolidated financial position as of June 30, 2026, the consolidated results of operations and statements of changes in shareholders' equity for the three and six months ended June 30, 2026 and 2025, and cash flows for the six months ended June 30, 2026, and 2025.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated results of operations for the three and six months ended June 30, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements of the Company as of and for the year ended December 31, 2025, as filed with the Company&#x2019;s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 27, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501155004613">
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss per share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="text-indent:-36pt;margin-left:72pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;asic loss per share is computed on the basis of net loss for the period divided by the weighted average number of outstanding ordinary shares, pre-funded warrants and vested restricted share units (&#x201c;RSUs&#x201d;) during the period. Each outstanding pre-funded warrant has no expiration and is exercisable at a price of NIS &lt;/span&gt;0.0000769&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt; per ordinary share.&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per share is based upon the weighted average number of ordinary shares and ordinary share equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, warrants and restricted share units (&#x201c;RSUs&#x201d;), which are included under the treasury stock method when dilutive. The calculation of diluted loss per share does not include options, warrants and RSUs exercisable into 31,712,061 ordinary shares and into 16,562,467 ordinary shares for the six months ended June 30, 2026 and 2025, respectively, and 34,357,716 ordinary shares and 17,068,031 ordinary shares for the three months ended June 30, 2026 and 2025, respectively, because the effect would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20260630"
      decimals="7"
      id="Fxbrl_20260804205526923"
      unitRef="NIS_per_Share">0.0000769</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260101to20260630"
      decimals="INF"
      id="Fxbrl_20260804205908901"
      unitRef="shares">31712061</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250101to20250630"
      decimals="INF"
      id="Fxbrl_20260804205920189"
      unitRef="shares">16562467</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20260401to20260630"
      decimals="INF"
      id="Fxbrl_20260804205932052"
      unitRef="shares">34357716</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20250401to20250630"
      decimals="INF"
      id="Fxbrl_20260804205943628"
      unitRef="shares">17068031</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260802200536422">
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:42.55pt;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:7.6%;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="text-indent:-58.35pt;margin-left:108pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:42.55pt;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:7.6%;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Observable prices that are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="text-indent:-58.35pt;margin-left:108pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:42.55pt;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:7.6%;vertical-align:top"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501155135990">
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:43pt;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Newly issued and recently adopted accounting pronouncements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recently issued accounting pronouncements not yet adopted&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2024, the FASB issued ASU&#160;2024-03 &#x201c;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&#x201d;, which requires disclosure about the types of costs and expenses included in certain expense captions presented on the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating this guidance to determine the impact it may have on its&#160;consolidated financial statements disclosures.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2025, the FASB issued ASU 2025-10 &#x201c;Government Grants (Topic 832)&#x201d; to establish authoritative guidance on the accounting for government grants received by business entities. This update is effective beginning with the Company&#x2019;s 2029 fiscal year annual reporting period, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <entx:IssuanceOfOrdinarySharesPrefundedWarrantsAndWarrantsTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260803001546814">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE&#160; 3 - ISSUANCE OF ORDINARY SHARES, PRE-FUNDED WARRANTS AND WARRANTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 1, 2026, the Company entered into a securities purchase agreement with certain funds affiliated with BVF Partners L.P. (collectively, &#x201c;BVF&#x201d;), providing for the private placement to BVF of an aggregate of 7,827,789 units (the &#x201c;2026 Units&#x201d;), each 2026 Unit consisting of (i) one ordinary share (or, in lieu thereof, one pre-funded warrant to purchase one ordinary share (the &#x201c;April 2026 Pre-Funded Warrants&#x201d;)) and (ii) one warrant to purchase one and one-half ordinary shares (the &#x201c;2026 Ordinary Share Warrants&#x201d;), for aggregate proceeds of approximately $10.0 million (or $1.2775 per 2026 Unit). On April 2, 2026 (the &#x201c;Closing Date&#x201d;), the Company issued 2,425,000 ordinary shares, 5,402,789 April 2026 Pre-Funded Warrants, and 11,741,683 2026 Ordinary Share Warrants in connection with this offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Each 2026 Ordinary Share Warrant has an exercise price of $&lt;span&gt;1.24&lt;/span&gt; per share, becomes exercisable six months following the Closing Date, expires five years from the date of issuance, and is subject to customary adjustments. The 2026 Ordinary Share Warrants are exercisable only for cash so long as the Company has an effective registration statement registering the shares underlying the 2026 Ordinary Share Warrants. The 2026 Pre-Funded Warrants have an exercise price of NIS 0.0000769 per share, are immediately exercisable and may be exercised at any time and have no expiration date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The 2026 Ordinary Share Warrants were classified as equity upon issuance, as they met the criteria for equity classification under ASC 815-40.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The April 2026 Pre-Funded Warrants were classified as a financial liability as they do not qualify for equity accounting under the indexation guide of ASC 815-40. The April 2026 Pre-Funded Warrants recorded at fair value on the Closing Date and will be remeasured to fair value at each subsequent reporting date, with changes in fair value recognized in financial expense, net in the statements of operations. The April 2026 Pre-Funded Warrants are classified as Level 2. The fair value was based on the quoted share price. The fair value of the pre-funded warrants as of the issuance date and as of June 30, 2026 was $6,807 and $9,563, respectively. As a result the Company recognized a change in fair value in an amount of $2,755.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:42.55pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25;margin-left:42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The proceeds from the private placement were allocated to the April 2026 Pre-Funded Warrants based on their fair value as of the issuance date. The residual proceeds were allocated to the Ordinary Shares and the 2026 Ordinary Share Warrants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25;margin-left:42pt;text-align:justify"&gt;&#160;&lt;/div&gt;
      &lt;div style="line-height:1.25;margin-left:42.55pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company had issuance costs of approximately $171 thousand. The portion of issuance costs allocated to the April 2026 Pre-Funded Warrants was recognized immediately in profit or loss, while the remaining portion allocated to the equity components was deducted from Additional Paid-in Capital.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  </entx:IssuanceOfOrdinarySharesPrefundedWarrantsAndWarrantsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260401to20260401_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260804210542490"
      unitRef="shares">7827789</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260401to20260401_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="-5"
      id="Fxbrl_20260501182344583"
      unitRef="USD">10000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20260401_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="4"
      id="Fxbrl_20260803182801816"
      unitRef="USD_per_Share">1.2775</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260402to20260402_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260501182501498"
      unitRef="shares">2425000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260402to20260402_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260501182903679"
      unitRef="shares">5402789</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260402to20260402_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260501182927054"
      unitRef="shares">11741683</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260402_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="2"
      id="Fxbrl_20260803003441125"
      unitRef="USD_per_Share">1.24</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260402_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="7"
      id="Fxbrl_20260803003538271"
      unitRef="NIS_per_Share">0.0000769</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <entx:FairValueOfPreFundedWarrants
      contextRef="C_20260401_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputSharePriceMember_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20260803010717444"
      unitRef="USD">6807000</entx:FairValueOfPreFundedWarrants>
    <entx:FairValueOfPreFundedWarrants
      contextRef="C_20260630_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputSharePriceMember_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20260803010742907"
      unitRef="USD">9563000</entx:FairValueOfPreFundedWarrants>
    <entx:GainLossOnFairValueChangePreFundedWarrants
      contextRef="C_20260401to20260630_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapMeasurementInputTypeAxis_usgaapMeasurementInputSharePriceMember_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20260803010805690"
      unitRef="USD">2755000</entx:GainLossOnFairValueChangePreFundedWarrants>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20260401to20260401_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="-3"
      id="Fxbrl_20260506101053271"
      unitRef="USD">171000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501162248399">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 4 - EQUITY AND SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Changes in Share Capital:&lt;br/&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 1, 2026, the Company issued 148,872 ordinary shares to five non-executive members of the board of directors in lieu of cash board fees for fiscal year 2025, which was approved by the Company&#x2019;s shareholders at a meeting of the Company&#x2019;s shareholders held on July 31, 2024. The fair value of the ordinary shares on the grant date was $289 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In February and April 2026, two former non-executive board members exercised options for an aggregate of 394,748 ordinary shares for total consideration of $260 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As to the issuance of ordinary shares to BVF see note 3.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div style="margin-left:45pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based Compensation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the six months ended June 30, 2026 the board of directors approved the following options grants:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="margin-left:72pt"&gt;
                  &lt;table border="0" cellpadding="2" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:10.96%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant Date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.72%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grantee&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vesting period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value at the grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Condition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:10.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;167,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;$1.94&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;(1)&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$227 thousand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td rowspan="6" style="width:10.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 7, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;612,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;$1.37&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;(2)&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$612 thousand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Executive Officers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,020,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2) (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;(3),(4)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service providers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;640,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;(3)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td rowspan="3" style="width:14.72%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83,367&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2) (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;(3), (5)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86,419&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1) (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;(3), (5)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Immediate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="background-color:rgb(204, 238, 255);border-width:1px;border-style:solid;border-color:rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;(3), (5)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Quarterly over a period of one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33.33% vest on the first anniversary of the date of grant and the remaining 66.67% of the options vest in eight equal quarterly installments following the first anniversary of the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The option grants are subject to the filing of a Form S-8 registration statement&#160;registering the ordinary shares underlying such options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;500,000 options grant was subject to the approval of the Company&#x2019;s shareholders which was obtained on July 14, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The grant was subject to the approval of the Company&#x2019;s shareholders which was obtained on July 14, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the event of the consummation of a Change in Control (as defined in the 2018 Plan) in which the Optionee continues to provide services to the Company on the date of consummation of such Change in Control, then 100% of any unvested Options at the time of consummation of such Change in Control shall become fully vested and exercisable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 7, 2026, the board of directors approved the grant of 734,428 RSUs to executive officers and service providers, of which grant 420,559 RSUs were subject to shareholder approval, which was obtained at a meeting of the Company&#x2019;s shareholders held on July 14, 2026. The RSUs vest in four equal quarterly installments over a one-year period that started on May 1, 2026. The fair value of the RSUs at the date of grant was $1,006&#160;thousand.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &#160;&lt;div&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of each option granted was estimated as of the date of grant using the Black-Scholes option-pricing model, using the following assumptions:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;margin-top:0pt;margin-bottom:0pt"&gt;
                      &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;Six months&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;ended June 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37-$1.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span&gt;-&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84.2%-84.8%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.74%-4.13%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life - in years&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.3-5.87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember"
      decimals="INF"
      id="Fxbrl_20231023161627495"
      unitRef="shares">148872</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_entxFiveNonExecutiveMembersMember"
      decimals="-3"
      id="Fxbrl_20250802130737395"
      unitRef="USD">289000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_20260201to20260228_srtTitleOfIndividualAxis_entxFormerNonExecutiveBoardMember"
      decimals="-3"
      id="Fxbrl_20260501170216704"
      unitRef="USD">394748000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260201to20260228_srtTitleOfIndividualAxis_entxFormerNonExecutiveBoardMember"
      decimals="-3"
      id="Fxbrl_20260501171222343"
      unitRef="USD">260000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260803110230820">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="margin-left:72pt"&gt;
                  &lt;table border="0" cellpadding="2" cellspacing="0" style="width:85%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:10.96%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant Date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.72%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grantee&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vesting period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value at the grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:middle;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Condition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:10.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;167,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;$1.94&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;(1)&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$227 thousand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td rowspan="6" style="width:10.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 7, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Employees&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;612,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;$1.37&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;(2)&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$612 thousand&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Executive Officers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,020,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2) (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;(3),(4)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.72%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service providers&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;640,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;(3)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td rowspan="3" style="width:14.72%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Directors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;83,367&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2) (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;(3), (5)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86,419&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1) (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="border-left:1px solid rgb(0, 0, 0);border-right:1px solid rgb(0, 0, 0);border-top:1px solid rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;(3), (5)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:14.27%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;40,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:12.84%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:17.96%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Immediate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:14.4%;vertical-align:bottom;background-color:rgb(204, 238, 255);border-top:1px solid rgb(0, 0, 0);border-left:1px solid rgb(0, 0, 0);border-bottom:1px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="background-color:rgb(204, 238, 255);border-width:1px;border-style:solid;border-color:rgb(0, 0, 0);vertical-align:bottom;width:14.72%"&gt;
                          &lt;div style="line-height:1.25"&gt;(3), (5)&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Quarterly over a period of one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33.33% vest on the first anniversary of the date of grant and the remaining 66.67% of the options vest in eight equal quarterly installments following the first anniversary of the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The option grants are subject to the filing of a Form S-8 registration statement&#160;registering the ordinary shares underlying such options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;500,000 options grant was subject to the approval of the Company&#x2019;s shareholders which was obtained on July 14, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The grant was subject to the approval of the Company&#x2019;s shareholders which was obtained on July 14, 2026.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the event of the consummation of a Change in Control (as defined in the 2018 Plan) in which the Optionee continues to provide services to the Company on the date of consummation of such Change in Control, then 100% of any unvested Options at the time of consummation of such Change in Control shall become fully vested and exercisable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 7, 2026, the board of directors approved the grant of 734,428 RSUs to executive officers and service providers, of which grant 420,559 RSUs were subject to shareholder approval, which was obtained at a meeting of the Company&#x2019;s shareholders held on July 14, 2026. The RSUs vest in four equal quarterly installments over a one-year period that started on May 1, 2026. The fair value of the RSUs at the date of grant was $1,006&#160;thousand.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110305210"
      unitRef="shares">167525</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110347422"
      unitRef="USD_per_Share">1.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260101to20260101_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="-3"
      id="Fxbrl_20260803110353509"
      unitRef="USD">227000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxEmployeesMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110808603"
      unitRef="shares">612000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxEmployeesMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110834573"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxEmployeesMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="-3"
      id="Fxbrl_20260803110907635"
      unitRef="USD">612000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110815061"
      unitRef="shares">1020000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_srtExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110838765"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxServiceProvidersMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110817941"
      unitRef="shares">640000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxServiceProvidersMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110842061"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110820829"
      unitRef="shares">83367</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_srtDirectorMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110848467"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxDirectorOneMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110824339"
      unitRef="shares">86419</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxDirectorOneMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110852667"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxDirectorTwoMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803110827308"
      unitRef="shares">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20260507to20260507_srtTitleOfIndividualAxis_entxDirectorTwoMember_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="2"
      id="Fxbrl_20260803110857324"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_20260101to20260630_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"
      decimals="4"
      id="Fxbrl_20260803113733849"
      unitRef="Pure">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_20260101to20260630_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheTwoMember"
      decimals="4"
      id="Fxbrl_20260803113739496"
      unitRef="Pure">0.6667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260101to20260630_usgaapAwardTypeAxis_usgaapStockCompensationPlanMember"
      decimals="INF"
      id="Fxbrl_20260803113902496"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20260507to20260507_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20260803120306259"
      unitRef="shares">734428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <entx:RsusSubjectToShareholderApproval
      contextRef="C_20260507to20260507_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20260803120320390"
      unitRef="shares">420559</entx:RsusSubjectToShareholderApproval>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20260507to20260507_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fxbrl_20260803120755716"
      unitRef="USD">1006000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260803100837043">
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;margin:auto"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;margin-top:0pt;margin-bottom:0pt"&gt;
                      &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;Six months&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;ended June 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$1.37-$1.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span&gt;-&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;84.2%-84.8%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;
                          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.74%-4.13%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected life - in years&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;
                        &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.3-5.87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20260630_srtRangeAxis_srtMinimumMember"
      decimals="2"
      id="Fxbrl_20260803100451905"
      unitRef="USD_per_Share">1.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20260630_srtRangeAxis_srtMaximumMember"
      decimals="2"
      id="Fxbrl_20260803100500085"
      unitRef="USD_per_Share">1.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20260101to20260630"
      decimals="2"
      id="Fxbrl_20260502000751406_xbrl_20231023162308206"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_20260101to20260630_srtRangeAxis_srtMinimumMember"
      decimals="3"
      id="Fxbrl_20260803100534644"
      unitRef="Pure">0.842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_20260101to20260630_srtRangeAxis_srtMaximumMember"
      decimals="3"
      id="Fxbrl_20260803100540619"
      unitRef="Pure">0.848</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_20260101to20260630_srtRangeAxis_srtMinimumMember"
      decimals="4"
      id="Fxbrl_20260803100602533"
      unitRef="Pure">0.0374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_20260101to20260630_srtRangeAxis_srtMaximumMember"
      decimals="4"
      id="Fxbrl_20260803100613564"
      unitRef="Pure">0.0413</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20260101to20260630_srtRangeAxis_srtMinimumMember"
      id="Fxbrl_20250802122622298">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20260101to20260630_srtRangeAxis_srtMaximumMember"
      id="Fxbrl_20260805010332428">P5Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <entx:SupplementaryFinancialStatementInformationTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260503143049801">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 5 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance sheets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

        &lt;div style="margin-left:45pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                &lt;td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other current assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:76%;vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="margin-left:11.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&#160;Receivable in respect of collaborative arrangement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:76%;vertical-align:bottom"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:11.65pt"&gt;VAT receivable&lt;/p&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;89&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;52&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                &lt;td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="text-align:justify;line-height:1.25;margin-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;465&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

        &lt;div style="margin-left:45pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accrued expenses and other payables:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Employees and employees related&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Provision for vacation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;726&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other payables (See Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;367&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,330&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </entx:SupplementaryFinancialStatementInformationTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20250802053612224">
        &lt;div style="margin-left:45pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                &lt;td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other current assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:76%;vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;216&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                &lt;td style="width:76%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="margin-left:11.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&#160;Receivable in respect of collaborative arrangement&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;219&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:76%;vertical-align:bottom"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:11.65pt"&gt;VAT receivable&lt;/p&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;89&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;vertical-align:bottom"&gt;52&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                &lt;td style="width:76%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="text-align:justify;line-height:1.25;margin-left:15pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;107&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;465&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;415&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103184253066_xbrl_20230731132636236_xbrl_20220808200953075_xbrl_20220510112546992"
      unitRef="USD">216000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184253066_xbrl_20230731132636236_xbrl_20220808200953075_xbrl_20220510112707928"
      unitRef="USD">37000</us-gaap:PrepaidExpenseCurrent>
    <entx:ReceivableInRespectOfCollaborativeArrangement
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20260501160205431_xbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112644305"
      unitRef="USD">16000</entx:ReceivableInRespectOfCollaborativeArrangement>
    <entx:ReceivableInRespectOfCollaborativeArrangement
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20260501160205431_xbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">219000</entx:ReceivableInRespectOfCollaborativeArrangement>
    <us-gaap:ValueAddedTaxReceivable
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20260804212156505"
      unitRef="USD">89000</us-gaap:ValueAddedTaxReceivable>
    <us-gaap:ValueAddedTaxReceivable
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20260804212206056"
      unitRef="USD">52000</us-gaap:ValueAddedTaxReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112644305"
      unitRef="USD">144000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184253075_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">107000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103184311257_xbrl_20240506181323372_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112644305"
      unitRef="USD">465000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184311257_xbrl_20240506181323372_xbrl_20230731132644516_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">415000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20250802053632508">
        &lt;div style="margin-left:45pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accrued expenses and other payables:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" rowspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Employees and employees related&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;264&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Provision for vacation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;238&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;168&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;391&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;726&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-align:justify;text-indent:14.2pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Other payables (See Note 6)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;367&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,330&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103184257516_xbrl_20220808200953075_xbrl_20220510112546992"
      unitRef="USD">293000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184257516_xbrl_20220808200953075_xbrl_20220510112707928"
      unitRef="USD">264000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250505224747238"
      unitRef="USD">238000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184257519_xbrl_20220808200953079_xbrl_20220510112732615"
      unitRef="USD">168000</us-gaap:AccruedVacationCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20260802200918728"
      unitRef="USD">391000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184257522_xbrl_20220808200953081_xbrl_20220510112742136"
      unitRef="USD">726000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20250505224654542"
      unitRef="USD">408000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20250505224704400"
      unitRef="USD">367000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20260630"
      decimals="-3"
      id="Fxbrl_20241103184306289_xbrl_20220808200953083_xbrl_20220510112657784"
      unitRef="USD">1330000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_20251231"
      decimals="-3"
      id="Fxbrl_20241103184306289_xbrl_20220808200953083_xbrl_20220510112751072"
      unitRef="USD">1525000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260501172305655">
    &lt;div&gt;
      &lt;div style="margin-right:36pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 6 - COLLABORATION AND RESEARCH AGREEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:28.35pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;line-height:1.25"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 16, 2025, the Company entered into a collaboration agreement with OPKO (the &#x201c;2025 Collaboration Agreement&#x201d;), which is accounted for as a collaboration arrangement within the scope of ASC 808.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Under the terms of the 2025 Collaboration Agreement, the Company and OPKO have agreed to collaborate with respect to the preclinical and clinical development and decision making related to the oral delivery of a dual agonist GLP-1/glucagon peptide in an oral dosage form using Entera&#x2019;s N-Tab&#x2122; technology platform for the treatment of obesity, metabolic and fibrotic disorders in humans. The Company and OPKO share in the economics and development costs of such program at 40% and 60%, respectively, subject to certain opt-out provisions. In connection with the agreement, the Company issued 3,685,226 ordinary shares to OPKO for aggregate gross proceeds of $8.0 million, which were allocated between equity and the collaboration components of the arrangement. Amounts allocated to the collaboration component are recognized over the period of performance and presented within other liabilities in the consolidated balance sheet.&lt;br/&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 3, 2026, the Company and OPKO amended and restated the 2025 Collaboration Agreement (the &#x201c;A&amp;amp;R Collaboration Agreement&#x201d;) to expand the scope of the collaboration to include the preclinical and clinical development of a daily LA-PTH tablet for the treatment of hypoparathyroidism (EB612) and additional indications. Development costs related to the LA-PTH program are shared equally between the parties. Except for the foregoing expansion, the material terms of the 2025 Collaboration Agreement remain unchanged.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the three and&#160;six months ended June 30, 2026, the Company recognized net expenses of $641 thousand and $1,164 thousand, respectively relating to the A&amp;amp;R Collaboration Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementNatureAndPurpose
      contextRef="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      id="Fxbrl_20250505233528450">Company and OPKO have agreed to collaborate with respect to the preclinical and clinical development and decision making related to the oral delivery of a dual agonist GLP-1/glucagon peptide in an oral dosage form using Entera&#x2019;s N-Tab&#x2122; technology platform for the treatment of obesity, metabolic and fibrotic disorders in humans. The Company and OPKO share in the economics and development costs of such program at 40% and 60%, respectively, subject to certain opt-out provisions.</us-gaap:CollaborativeArrangementNatureAndPurpose>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="INF"
      id="Fxbrl_20250505233547681"
      unitRef="shares">3685226</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="C_20250311to20250316_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="-5"
      id="Fxbrl_20250505233604451"
      unitRef="USD">8000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OperatingExpenses
      contextRef="C_20260401to20260630_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="-3"
      id="Fxbrl_20250802065759982"
      unitRef="USD">641000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20260101to20260630_usgaapTypeOfArrangementAxis_entxOpkoBiologicsLtdMember"
      decimals="-3"
      id="Fxbrl_20260802201500526"
      unitRef="USD">1164000</us-gaap:OperatingExpenses>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260503150859901">
    &lt;div&gt;
      &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 7 - SEGMENT INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;The Company operates in Israel as a &lt;span style="-sec-ix-hidden:Fxbrl_20260804213855092"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20260804213019803"&gt;single&lt;/span&gt;&lt;/span&gt; operating segment. The Company&#x2019;s Chief Executive Officer is the chief operating decision maker (the &#x201c;CODM&#x201d;). The CODM makes decisions on resource allocation, assesses performance of the business and monitors budget versus actual results on a consolidated basis. The CODM reviews the Company's consolidated results of operations through income (loss) before income taxes.&lt;/p&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

          &lt;tr&gt;
            &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top"&gt;
              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment information:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr&gt;
            &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
            &lt;td style="width:auto;vertical-align:top"&gt;&#160;&lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;

        &lt;div&gt;
          &lt;div style="margin-left:72pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Six&#160;Months&#160;Ended&#160;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three&#160;Months&#160;Ended&#160;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;42&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development, net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sub-contractors and consulting expense (EB613)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;2,334&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;972&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;1,554&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;599&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net expenses related to OPKO Collaboration Agreement&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;1,164&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;120&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;641&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;120&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payroll and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;919&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;766&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;484&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;372&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;690&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;470&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;377&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;294&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;252&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;226&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;124&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;103&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other development expenses*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;93&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;89&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;21&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;32&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other segment expenses**&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,622&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,111&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,136&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;10,817&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;5,223&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;7,312&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;2,656&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* Other development expenses include materials and productions and others.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:45pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;** Other segment expenses mainly related to general and administrative expenses, including payroll and related expenses, share-based compensation, legal and audit fees and others.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260804213049529">The Company&#x2019;s Chief Executive Officer is the chief operating decision maker (the &#x201c;CODM&#x201d;).</us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260802201928935">
        &lt;div&gt;
          &lt;div style="margin-left:72pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Six&#160;Months&#160;Ended&#160;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Three&#160;Months&#160;Ended&#160;June&#160;30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;42&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;-&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development, net:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sub-contractors and consulting expense (EB613)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;2,334&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;972&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;1,554&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;599&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net expenses related to OPKO Collaboration Agreement&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;1,164&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;120&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;641&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;120&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Payroll and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;919&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;766&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;484&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;372&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;690&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;470&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;377&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;294&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rent and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;252&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;226&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;124&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;103&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="margin-left:14.25pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other development expenses*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;93&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;89&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;21&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;32&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other segment expenses**&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,365&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,622&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,111&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,136&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:1.25"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Segment net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;10,817&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;5,223&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;7,312&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;2,656&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:45pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* Other development expenses include materials and productions and others.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:45pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;** Other segment expenses mainly related to general and administrative expenses, including payroll and related expenses, share-based compensation, legal and audit fees and others.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144884_xbrl_20250802133250157_211"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144884_xbrl_20250802133250157_215"
      unitRef="USD">42000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_211"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_215"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144887_xbrl_20250802133250157_511"
      unitRef="USD">2334000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144887_xbrl_20250802133250157_515"
      unitRef="USD">972000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_511"
      unitRef="USD">1554000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_515"
      unitRef="USD">599000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144890_xbrl_20250802133250157_63"
      unitRef="USD">1164000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144890_xbrl_20250802133250157_611"
      unitRef="USD">120000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_63"
      unitRef="USD">641000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <entx:NetExpensesRelatedToOpkoCollaborationAgreement
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_611"
      unitRef="USD">120000</entx:NetExpensesRelatedToOpkoCollaborationAgreement>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144892_xbrl_20250802133250157_711"
      unitRef="USD">919000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144892_xbrl_20250802133250157_715"
      unitRef="USD">766000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_711"
      unitRef="USD">484000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_715"
      unitRef="USD">372000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144895_xbrl_20250802133250157_811"
      unitRef="USD">690000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144895_xbrl_20250802133250157_815"
      unitRef="USD">470000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_811"
      unitRef="USD">377000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_815"
      unitRef="USD">294000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144897_xbrl_20250802133250157_911"
      unitRef="USD">252000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144897_xbrl_20250802133250157_915"
      unitRef="USD">226000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_911"
      unitRef="USD">124000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_915"
      unitRef="USD">103000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherExpenses
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144899_xbrl_20250802133250157_1011"
      unitRef="USD">93000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144899_xbrl_20250802133250157_1015"
      unitRef="USD">89000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_1011"
      unitRef="USD">21000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_1015"
      unitRef="USD">32000</us-gaap:OtherExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
      unitRef="USD">5365000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
      unitRef="USD">2622000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_1111"
      unitRef="USD">4111000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_1115"
      unitRef="USD">1136000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260101to20260630"
      decimals="-3"
      id="Fxbrl_20260802202144904_xbrl_20250802133250157_1211"
      unitRef="USD">-10817000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250101to20250630"
      decimals="-3"
      id="Fxbrl_20260802202144904_xbrl_20250802133250157_1215"
      unitRef="USD">-5223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20260401to20260630"
      decimals="-3"
      id="Fxbrl_20250802133250157_1211"
      unitRef="USD">-7312000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20250401to20250630"
      decimals="-3"
      id="Fxbrl_20250802133250157_1215"
      unitRef="USD">-2656000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260508183944253">
    &lt;div&gt;
      &lt;p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0.5in 0pt 0;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 8 - SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;On July 14, 2026, the Company's shareholders approved an increase in the Company's authorized shares to 350,000,000.&lt;/p&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 26, 2026, the Company entered into a securities purchase agreement (the &#x201c;July 2026 Purchase Agreement&#x201d;) with certain institutional and accredited investors, including funds affiliated with BVF providing for the private placement&#160;(the &#x201c;July 2026 Private Placement&#x201d;) of an aggregate of 134,803,910 ordinary shares, or, in lieu thereof, pre-funded warrants to purchase Ordinary Shares (the &#x201c;July 2026 Pre-Funded Warrants&#x201d;), at a purchase price of $2.04 per Ordinary Share, for aggregate gross proceeds of approximately $275.0 million, before deducting placement agent fees and other related offering expenses.&#160;&lt;br/&gt;&#160;&lt;br/&gt;On July 28, 2026 (the &#x201c;Closing Date&#x201d;), the Company issued 122,961,215 ordinary shares and July 2026 Pre-Funded Warrants to purchase 11,842,695 ordinary shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The July 2026 Pre-Funded Warrants have an exercise price of NIS 0.0000769 per ordinary share, are immediately exercisable, do not expire and are subject to customary beneficial ownership limitations and adjustments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company intends to use the net proceeds from the July 2026 Private Placement to support activities related to the initiation of its Phase 3 registrational study of EB613 in postmenopausal women with osteoporosis and for general working capital and corporate purposes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to the July 2026 Purchase Agreement, effective upon the closing of the July 2026 Private Placement, the Company also granted BVF certain rights to designate two nominees to the Company&#x2019;s board of directors, subject to specified ownership thresholds and other conditions as set forth in the July 2026 Purchase Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:auto;text-align:justify;vertical-align:top"&gt;
                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In July 2026, certain holders of warrants issued in the Company&#x2019;s 2023 private placement exercised an aggregate of 431,137 warrants and 906,886 pre-funded warrants for aggregate gross proceeds to the Company of $431 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:auto;text-align:justify;vertical-align:top"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;
                &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:auto;text-align:justify;vertical-align:top"&gt;
                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On August 5, 2026, the Company issued 107,770 ordinary shares to five non-executive members of the board of directors in lieu of cash board fees for the first quarter and the second quarter of 2026, which was approved by the Company&#x2019;s shareholders at a meeting of the Company&#x2019;s shareholders held on July 31, 2024.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:auto;text-align:justify;vertical-align:top"&gt;&#160;&lt;/td&gt;
            &lt;/tr&gt;
            &lt;tr&gt;
              &lt;td style="width:45pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;
                &lt;p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;/td&gt;
              &lt;td style="width:auto;text-align:justify;vertical-align:top"&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;In September 2022, the Company&#x2019;s shareholders approved to Ms. Miranda Toledano, the Company&#x2019;s Chief Executive Officer, a grant of options to purchase 200,000 ordinary shares, subject to the occurrence of a triggering event, defined as either (i) the execution of a binding strategic or partnership agreement to fund the Company&#x2019;s Phase 3 clinical trial or (ii) raising sufficient funding to complete the Company&#x2019;s Phase 3 clinical trial. Following the closing of the July 2026 Private Placement, the second triggering event was satisfied. On August 5, 2026, the Board of Directors approved the grant of the 200,000 options at an exercise price of $2.81 per share. The options vest over four years, with 25% of the options vest on the first anniversary of the date of grant and the remaining 75% of the options vest in twelve equal quarterly installments following the first anniversary of the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260701to20260714_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20260804213614434"
      unitRef="shares">350000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260701to20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260501182319742"
      unitRef="shares">134803910</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="3"
      id="Fxbrl_20260501182334639"
      unitRef="USD_per_Share">2.04</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260701to20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="-3"
      id="Fxbrl_20260803182715638"
      unitRef="USD">275000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260701to20260728_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260803182818433"
      unitRef="shares">122961215</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20260728_usgaapStatementEquityComponentsAxis_entxOrdinaryShareWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember_usgaapTypeOfArrangementAxis_entxBvfPartnersLpMember"
      decimals="INF"
      id="Fxbrl_20260803183047893"
      unitRef="shares">11842695</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20260726_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember"
      decimals="7"
      id="Fxbrl_20260803015526569"
      unitRef="NIS_per_Share">0.0000769</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260701to20260726_usgaapStatementEquityComponentsAxis_usgaapWarrantMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_entxTwoZeroTwoThreePrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260803015621411"
      unitRef="shares">431137</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20260701to20260726_usgaapStatementEquityComponentsAxis_entxTwoZeroTwoSixPrefundedWarrantsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_entxTwoZeroTwoThreePrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20260803015624844"
      unitRef="shares">906886</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20260701to20260726_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_entxTwoZeroTwoThreePrivatePlacementMember"
      decimals="-6"
      id="Fxbrl_20260803015634353"
      unitRef="USD">431000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260801to20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_entxFiveNonExecutiveBoardMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20260807200516814"
      unitRef="shares">107770</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220901to20220930_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fxbrl_20260807202628625"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20260801to20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtDirectorMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="INF"
      id="Fxbrl_20260807202913724"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtDirectorMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="2"
      id="Fxbrl_20260807203013428"
      unitRef="USD_per_Share">2.81</us-gaap:SharesIssuedPricePerShare>
    <entx:OptionsVestingTerm
      contextRef="C_20260801to20260805_usgaapRelatedPartyTransactionsByRelatedPartyAxis_srtDirectorMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      id="Fxbrl_20260807203204260">The options vest over four years, with 25% of the options vest on the first anniversary of the date of grant and the remaining 75% of the options vest in twelve equal quarterly installments following the first anniversary of the grant date.</entx:OptionsVestingTerm>
    <ecd:MtrlTermsOfTrdArrTextBlock
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260326002013943">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the quarter ended June 30, 2026, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any &#x201c;non-Rule 10b5-1 trading arrangement&#x201d;, as defined in Item 408 of Regulation S-K.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndTitle
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260326002039201">officers or directors</ecd:TrdArrIndTitle>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260805005153871">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260326002124373">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260805005212715">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_20260101to20260630"
      id="Fxbrl_20260326002429713">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnote id="FN20250802115348372" xlink:label="FN20250802115348372" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount less than one thousand U.S. dollars.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:label="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802111805109_xbrl_20250802111419637_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802111812981_xbrl_20250802111441199_xbrl_20241103185440876_xbrl_20240802154555482_xbrl_20240802154451833_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802112727740_xbrl_20250802112520437_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20251107164113212"
          xlink:label="Fxbrl_20251107164113212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20251107164113212"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803123957508_xbrl_20251107164113212"
          xlink:label="Fxbrl_20260803123957508_xbrl_20251107164113212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803123957508_xbrl_20251107164113212"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803123957508_xbrl_20241103185545567_xbrl_20240802153133562_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:label="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211788_46"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:label="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213010689_xbrl_20220802040425371_20220801223211790_49"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803124111558_xbrl_20241103185447773_xbrl_20240506234256782_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803130100436_xbrl_20260803125745046_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803133924606_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803133928646_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:label="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260803133931529_xbrl_20241103185431541_xbrl_20231023162002686_xbrl_20230731141841214_xbrl_20230731141637538_xbrl_20230731140510423_xbrl_20220808213523162"
          xlink:to="FN20250802115348372"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802133250157_1011"
          xlink:label="Fxbrl_20250802133250157_1011"
          xlink:type="locator"/>
        <link:footnote id="FN20251107102019556" xlink:label="FN20251107102019556" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other development expenses include materials and productions and others.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802133250157_1011"
          xlink:to="FN20251107102019556"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802133250157_1015"
          xlink:label="Fxbrl_20250802133250157_1015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802133250157_1015"
          xlink:to="FN20251107102019556"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802133250157_1111"
          xlink:label="Fxbrl_20250802133250157_1111"
          xlink:type="locator"/>
        <link:footnote id="FN20260501174844644" xlink:label="FN20260501174844644" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other segment expenses mainly related to general and administrative expenses, including payroll and related expenses, share-based compensation, legal and audit fees and others.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802133250157_1111"
          xlink:to="FN20260501174844644"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20250802133250157_1115"
          xlink:label="Fxbrl_20250802133250157_1115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20250802133250157_1115"
          xlink:to="FN20260501174844644"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260802202144899_xbrl_20250802133250157_1015"
          xlink:label="Fxbrl_20260802202144899_xbrl_20250802133250157_1015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260802202144899_xbrl_20250802133250157_1015"
          xlink:to="FN20251107102019556"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260802202144899_xbrl_20250802133250157_1011"
          xlink:label="Fxbrl_20260802202144899_xbrl_20250802133250157_1011"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260802202144899_xbrl_20250802133250157_1011"
          xlink:to="FN20251107102019556"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
          xlink:label="Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260802202144902_xbrl_20250802133250157_1115"
          xlink:to="FN20260501174844644"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
          xlink:label="Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260802202144902_xbrl_20250802133250157_1111"
          xlink:to="FN20260501174844644"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
